Solosec is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Ropack Inc.. The primary component is Secnidazole.
Product ID | 64811-401_84b2ccb5-fe73-4b3d-e053-2a91aa0a3710 |
NDC | 64811-401 |
Product Type | Human Prescription Drug |
Proprietary Name | Solosec |
Generic Name | Secnidazole |
Dosage Form | Granule |
Route of Administration | ORAL |
Marketing Start Date | 2018-03-01 |
Marketing Category | NDA / NDA |
Application Number | NDA209363 |
Labeler Name | Ropack Inc. |
Substance Name | SECNIDAZOLE |
Active Ingredient Strength | 2 g/4.8g |
Pharm Classes | Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-03-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Ingredient | Strength |
---|---|
SECNIDAZOLE | 2 g/4.8g |
SPL SET ID: | b182b7f1-34ea-4c3f-8bf0-df35e83e73e2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
27437-051 | SOLOSEC | secnidazole |
64811-401 | Solosec | SECNIDAZOLE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SOLOSEC 86696432 5498160 Live/Registered |
Symbiomix Therapeutics, LLC 2015-07-17 |